These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 31196136

  • 1. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
    Zhao J, Wozniak A, Adams A, Cox J, Vittal A, Voss J, Bridges B, Weinman SA, Li Z.
    J Exp Clin Cancer Res; 2019 Jun 13; 38(1):252. PubMed ID: 31196136
    [Abstract] [Full Text] [Related]

  • 2. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.
    Ran LK, Chen Y, Zhang ZZ, Tao NN, Ren JH, Zhou L, Tang H, Chen X, Chen K, Li WY, Huang AL, Chen J.
    Clin Cancer Res; 2016 Jul 01; 22(13):3372-82. PubMed ID: 26861461
    [Abstract] [Full Text] [Related]

  • 3. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J, Zhang N, Sun H, Su L, Zhang C, Xu H, Feng J, Wang M, Chen J, Liu L, Shan J, Shen J, Yang Z, Wang G, Zhou H, Prieto J, Ávila MA, Liu C, Qian C.
    Gastroenterology; 2020 Feb 01; 158(3):664-678.e24. PubMed ID: 31678303
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological and molecular analysis of SIRT7 in hepatocellular carcinoma.
    Yanai M, Kurata M, Muto Y, Iha H, Kanao T, Tatsuzawa A, Ishibashi S, Ikeda M, Kitagawa M, Yamamoto K.
    Pathology; 2020 Aug 01; 52(5):529-537. PubMed ID: 32586688
    [Abstract] [Full Text] [Related]

  • 5. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
    Kim JK, Noh JH, Jung KH, Eun JW, Bae HJ, Kim MG, Chang YG, Shen Q, Park WS, Lee JY, Borlak J, Nam SW.
    Hepatology; 2013 Mar 01; 57(3):1055-67. PubMed ID: 23079745
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C, Wu M, Zong G, Wan C, Liu Q, Zhou H, Hua L, Chen Y, Chen X, Lu C.
    Dig Dis Sci; 2017 Jan 01; 62(1):133-142. PubMed ID: 27921263
    [Abstract] [Full Text] [Related]

  • 7. Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation.
    Liu L, Chen X, Xie S, Zhang C, Qiu Z, Zhu F.
    Hepatology; 2012 Nov 01; 56(5):1760-9. PubMed ID: 22576474
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H, Wang J, Yin J, Lu B, Yang Q, Wan Y, Jia C.
    Cell Physiol Biochem; 2018 Nov 01; 45(3):1121-1135. PubMed ID: 29439259
    [Abstract] [Full Text] [Related]

  • 9. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
    Li X, Yu J, Brock MV, Tao Q, Herman JG, Liang P, Guo M.
    Oncotarget; 2015 May 10; 6(13):11547-60. PubMed ID: 25909168
    [Abstract] [Full Text] [Related]

  • 10. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
    Ye J, Liang R, Bai T, Lin Y, Mai R, Wei M, Ye X, Li L, Wu F.
    J Exp Clin Cancer Res; 2018 Sep 03; 37(1):212. PubMed ID: 30176896
    [Abstract] [Full Text] [Related]

  • 11. WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.
    Liu H, Chen W, Liang C, Chen BW, Zhi X, Zhang S, Zheng X, Bai X, Liang T.
    Cancer Lett; 2015 Jun 01; 361(2):218-25. PubMed ID: 25749422
    [Abstract] [Full Text] [Related]

  • 12. Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy.
    Tang Y, Chen K, Luan X, Zhang J, Liu R, Zheng X, Xie S, Ke H, Zhang X, Chen W.
    Int J Oncol; 2020 Dec 01; 57(6):1368-1380. PubMed ID: 33174013
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CYP2E1-dependent upregulation of SIRT7 is response to alcohol mediated metastasis in hepatocellular carcinoma.
    Zhang C, Zhao J, Zhao J, Liu B, Tang W, Liu Y, Huang W, Weinman SA, Li Z.
    Cancer Gene Ther; 2022 Dec 01; 29(12):1961-1974. PubMed ID: 35902730
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
    Wang JL, Yang MY, Xiao S, Sun B, Li YM, Yang LY.
    J Exp Clin Cancer Res; 2018 Mar 05; 37(1):45. PubMed ID: 29506567
    [Abstract] [Full Text] [Related]

  • 20. Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism.
    Giovannini C, Gramantieri L, Chieco P, Minguzzi M, Lago F, Pianetti S, Ramazzotti E, Marcu KB, Bolondi L.
    J Hepatol; 2009 May 05; 50(5):969-79. PubMed ID: 19304334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.